Literature DB >> 26658506

LIM Kinase, a Newly Identified Regulator of Presynaptic Remodeling by Rod Photoreceptors After Injury.

Weiwei Wang, Ellen Townes-Anderson.   

Abstract

PURPOSE: Rod photoreceptors retract their axon terminals and develop neuritic sprouts in response to retinal detachment and reattachment, respectively. This study examines the role of LIM kinase (LIMK), a component of RhoA and Rac pathways, in the presynaptic structural remodeling of rod photoreceptors.
METHODS: Phosphorylated LIMK (p-LIMK), the active form of LIMK, was examined in salamander retina with Western blot and confocal microscopy. Axon length within the first 7 hours and process growth after 3 days of culture were assessed in isolated rod photoreceptors treated with inhibitors of upstream regulators ROCK and p21-activated kinase (Pak) (Y27632 and IPA-3) and a direct LIMK inhibitor (BMS-5). Porcine retinal explants were also treated with BMS-5 and analyzed 24 hours after detachment. Because Ca2+ influx contributes to axonal retraction, L-type channels were blocked in some experiments with nicardipine.
RESULTS: Phosphorylated LIMK is present in rod terminals during retraction and in newly formed processes. Axonal retraction over 7 hours was significantly reduced by inhibition of LIMK or its regulators, ROCK and Pak. Process growth was reduced by LIMK or Pak inhibition especially at the basal (axon-bearing) region of the rod cells. Combining Ca2+ channel and LIMK inhibition had no additional effect on retraction but did further inhibit sprouting after 3 days. In detached porcine retina, LIMK inhibition reduced rod axonal retraction and improved retinal morphology.
CONCLUSIONS: Thus structural remodeling, in the form of either axonal retraction or neuritic growth, requires LIMK activity. LIM kinase inhibition may have therapeutic potential for reducing pathologic rod terminal plasticity after retinal injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26658506      PMCID: PMC4682489          DOI: 10.1167/iovs.15-17278

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  99 in total

1.  Synaptic plasticity in mammalian photoreceptors prepared as sheets for retinal transplantation.

Authors:  Mohamad A Khodair; Marco A Zarbin; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

2.  Dual regulation of LIM kinase 1 expression by cyclic AMP and calcium determines cofilin phosphorylation states during neuritogenesis in NG108-15 cells.

Authors:  Takuro Tojima; Masayuki Takahashi; Etsuro Ito
Journal:  Brain Res       Date:  2003-09-19       Impact factor: 3.252

Review 3.  Rhegmatogenous retinal detachment--an ophthalmologic emergency.

Authors:  Nicolas Feltgen; Peter Walter
Journal:  Dtsch Arztebl Int       Date:  2014-01-06       Impact factor: 5.594

Review 4.  Actin dynamics in vivo.

Authors:  M D Welch; A Mallavarapu; J Rosenblatt; T J Mitchison
Journal:  Curr Opin Cell Biol       Date:  1997-02       Impact factor: 8.382

5.  LIM kinase 1 activates cAMP-responsive element-binding protein during the neuronal differentiation of immortalized hippocampal progenitor cells.

Authors:  Eun Jin Yang; Joo-Heon Yoon; Do Sik Min; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

6.  eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.

Authors:  Annarita Di Lorenzo; Michelle I Lin; Takahisa Murata; Shira Landskroner-Eiger; Michael Schleicher; Milankumar Kothiya; Yasuko Iwakiri; Jun Yu; Paul L Huang; William C Sessa
Journal:  J Cell Sci       Date:  2013-09-17       Impact factor: 5.285

Review 7.  Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression.

Authors:  Geoffrey P Lewis; Steven K Fisher
Journal:  Int Rev Cytol       Date:  2003

8.  Protein kinase C activation decreases peripheral actin network density and increases central nonmuscle myosin II contractility in neuronal growth cones.

Authors:  Qing Yang; Xiao-Feng Zhang; David Van Goor; Ashleigh P Dunn; Callen Hyland; Nelson Medeiros; Paul Forscher
Journal:  Mol Biol Cell       Date:  2013-08-21       Impact factor: 4.138

9.  Combined p21-activated kinase and farnesyltransferase inhibitor treatment exhibits enhanced anti-proliferative activity on melanoma, colon and lung cancer cell lines.

Authors:  Giampiero Porcu; Ainslie B Parsons; Daniele Di Giandomenico; Giuseppe Lucisano; Maria Giovanna Mosca; Charles Boone; Antonella Ragnini-Wilson
Journal:  Mol Cancer       Date:  2013-08-06       Impact factor: 27.401

10.  Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.

Authors:  Karin Zins; Sandun Gunawardhana; Trevor Lucas; Dietmar Abraham; Seyedhossein Aharinejad
Journal:  J Transl Med       Date:  2013-11-27       Impact factor: 5.531

View more
  11 in total

Review 1.  Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology.

Authors:  Nuno Moura-Coelho; Joana Tavares Ferreira; Carolina Pereira Bruxelas; Marco Dutra-Medeiros; João Paulo Cunha; Rita Pinto Proença
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-07       Impact factor: 3.117

2.  Effects of Hippocampal LIMK Inhibition on Memory Acquisition, Consolidation, Retrieval, Reconsolidation, and Extinction.

Authors:  Paula Lunardi; Ricardo Marcelo Sachser; Rodrigo Ordoñez Sierra; Lizeth Katherine Pedraza; Candela Medina; Verónica de la Fuente; Arturo Romano; Jorge Alberto Quillfeldt; Lucas de Oliveira Alvares
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

3.  RhoA Signaling and Synaptic Damage Occur Within Hours in a Live Pig Model of CNS Injury, Retinal Detachment.

Authors:  Jianfeng Wang; Marco Zarbin; Ilene Sugino; Ian Whitehead; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

Review 4.  Lim kinase, a bi-functional effector in injury-induced structural plasticity of synapses.

Authors:  Weiwei Wang; Ellen Townes-Anderson
Journal:  Neural Regen Res       Date:  2016-07       Impact factor: 5.135

5.  Fasudil, a Clinically Used ROCK Inhibitor, Stabilizes Rod Photoreceptor Synapses after Retinal Detachment.

Authors:  Ellen Townes-Anderson; Jianfeng Wang; Éva Halász; Ilene Sugino; Amy Pitler; Ian Whitehead; Marco Zarbin
Journal:  Transl Vis Sci Technol       Date:  2017-06-20       Impact factor: 3.283

6.  Sema3A Reduces Sprouting of Adult Rod Photoreceptors In Vitro.

Authors:  Frank Kung; Weiwei Wang; Tracy S Tran; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

Review 7.  Novel Therapeutics in Glaucoma Management.

Authors:  Claudio Bucolo; Chiara Bianca Maria Platania; Filippo Drago; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Maurizio Uva
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  Actin Dynamics, Regulated by RhoA-LIMK-Cofilin Signaling, Mediates Rod Photoreceptor Axonal Retraction After Retinal Injury.

Authors:  Weiwei Wang; Eva Halasz; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

9.  LIM kinases in synaptic plasticity and their potential as therapeutic targets.

Authors:  Eva Halasz; Ellen Townes-Anderson; Weiwei Wang
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

Review 10.  RhoA-ROCK Signaling as a Therapeutic Target in Traumatic Brain Injury.

Authors:  Shalaka Mulherkar; Kimberley F Tolias
Journal:  Cells       Date:  2020-01-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.